Circulating SARS-CoV-2 variants B.1.1.7, 501Y.V2, and P.1 have gained ability to utilize rat and mouse Ace2 and altered in vitro sensitivity to neutralizing antibodies and ACE2-Ig

Africa, America, Animals, B.1.1.7, B.1.351, Brazil, Coronavirus, England, Europe, Health, Infection, Mutation, N501Y, P.1, Reinfection, Science, Scotland, South Africa, UK, Vaccine, Variants, Wales

Here, we first investigated cross-species receptor usage of multiple SARS-CoV-2 variants that emerged during the pandemic. We found that, in contrast to an early isolate WHU01, the circulating variants B.1.1.7/501Y.V1, B.1.351/501Y.V2, and P.1/501Y.V3 were able to use rat and mouse Ace2 orthologs as entry receptors, suggesting that rats and mice might be able to harbor and spread these variants.


Image by Karsten Paulick from Pixabay

** This post was originally published on February 1, 2021 **